Impact of the Australia-US Free Trade Agreement on Australian medicines regulation and prices

Date

Authors

Bai, J.

Nguyen, Duy

Faunce, Thomas

Publisher

Palgrave Macmillan Ltd

Abstract

The Australia-United States Free Trade Agreement (AUSFTA) came into force on 1 January 2005. Before and subsequently to the AUSFTA being concluded, controversy surrounded the debate over its impact on Australia's health policy, specifically on regulation

Keywords

Keywords: atorvastatin; bromocriptine; etiracetam; generic drug; lamotrigine; olanzapine; pramipexole; quetiapine; risperidone; rosuvastatin; Australia; Australia United States Free Trade Agreement; competition; cost effectiveness analysis; cost minimization analys Data exclusivity; Evergreening; Innovation; Pharmaceutical benefi ts scheme; Reference pricing; Trade agreement

URI

http://hdl.handle.net/1885/51254

Collections

ANU Research Publications

Source

Journal of Generic Medicines

Type

Journal article

DOI

10.1057/jgm.2009.40

Restricted until

2037-12-31

Downloads

File

Description

01_Faunce_Impact_of_the_Australia-US_2010.pdf (546.99 KB)

02_Faunce_Impact_of_the_Australia-US_2010.pdf (755.39 KB)